-
Mashup Score: 0How to Prevent and Prepare for Cyberattacks - 2 hour(s) ago
The time to think about handling a cyberattack is not during an attack, according to Joyce Oh, vice president and chief information officer at Moffitt Cancer Center. Cyberattacks against health systems are becoming more common, but health care providers can take steps to prevent cyberattacks or stop them from derailing patient care.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
HRR testing is underused in patients with metastatic castration-resistant prostate cancer, a large study suggests.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Black adolescent and young adult cancer survivors may be less likely than their peers of other races and ethnicities to have a live birth after cancer, data suggest.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
Another study adds to research suggesting that assisted reproductive technology may increase the risk of leukemia in offspring.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0USPSTF Lowers Recommended Age for Breast Cancer Screening - 5 day(s) ago
The USPSTF recommends that women aged 40 to 74 years undergo breast cancer screening mammography every other year. This recommendation applies to anyone assigned female at birth who is at average risk of breast cancer. Women aged 40 to 74 years should undergo breast cancer screening with mammography every 2 years, the USPSTF recommends.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1HER2 CAR-T Cells Show Activity in Advanced Sarcoma - 6 day(s) ago
Treatment with autologous HER2-specifc CAR T cells was considered tolerable and produced responses in a phase 1 trial of patients with advanced sarcoma.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Cancer drugs approved under the FDA’s Real-Time Oncology Review program may not be supported by adequate trial data, researchers suggested.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
People with cancer have an increased risk of dying from COVID-19, according to 2 large studies from the United States and the United Kingdom.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Hypofractionated IMRT and Concurrent Chemo Considered Well Tolerated in Cervical Cancer - 9 day(s) ago
Hypofractionated IMRT with concurrent chemotherapy appears to be well tolerated as post-operative treatment in patients with cervical cancer.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Roughly 11% of active pharmaceutical ingredients produced for the US market were linked to generic drug shortages in 2020 and 2021.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
HCPs can take steps to prevent #cyberattacks or at least stop them from derailing patient care. Featuring interviews with @TedOkonCOA from @oncologyCOA, Kate Pierce from @FortifiedHITSec, Joyce Oh from @MoffittNews, and Anthony Cartwright from @CCAD. https://t.co/CeuL4Pco7K